A Prospective Phase II Dose Escalation Study Using IMRT for High Risk N0 M0 Prostate Cancer. ICORG 08-17
Cancer Trials Ireland
Cancer Trials Ireland
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University Health Network, Toronto
NRG Oncology
NRG Oncology
University Health Network, Toronto
Eastern Cooperative Oncology Group
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
University Health Network, Toronto
Jonsson Comprehensive Cancer Center
Umeå University
Royal North Shore Hospital
Royal North Shore Hospital
Washington University School of Medicine
RTOG Foundation, Inc.
Mayo Clinic
Stanford University
Milton S. Hershey Medical Center
Northwestern University
Centre Antoine Lacassagne
Ohio State University Comprehensive Cancer Center
City of Hope Medical Center
Takeda
Medical College of Wisconsin
University of Texas Southwestern Medical Center
University Hospital, Essen
Milton S. Hershey Medical Center
Eastern Cooperative Oncology Group
University Hospital Freiburg
CancerCare Manitoba
OHSU Knight Cancer Institute
National Cancer Institute (NCI)
University of Texas Southwestern Medical Center
NYU Langone Health
Jonsson Comprehensive Cancer Center
University Hospital, Geneva
Fox Chase Cancer Center
NRG Oncology
Mayo Clinic
Abramson Cancer Center at Penn Medicine
Stanford University
The Netherlands Cancer Institute
National Institutes of Health Clinical Center (CC)
ChineseAMS
Beth Israel Medical Center
National Cancer Institute (NCI)
Mayo Clinic